Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study

Abstract

BackgroundChondrosarcoma is the most common primary bone sarcoma among elderly population. This study aims to explore independent prognostic factors and develop prediction model in elderly patients with CHS.MethodsThis study retrospectively analyzed the clinical data of elderly patients diagnosed as CHS between 2004 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. We randomly divided enrolled patients into training and validation group, univariate and multivariate Cox regression analyses were used to determine independent prognostic factors. Based on the identified variables, the nomogram was developed and verified to predict the 12-, 24-, and 36-month overall survival (OS) of elderly patients with CHS. A k-fold cross-validation method (k=10) was performed to validate the newly proposed model. The discrimination, calibration and clinical utility of the nomogram were assessed using the Harrells concordance index (C-index), receiver operating characteristic (ROC) curve and the area under the curve (AUC), calibration curve, decision curve analysis (DCA), the integrated discrimination improvement (IDI) and net reclassification index (NRI). Furthermore, a web-based survival calculator was developed based on the nomogram.ResultsThe study finally included 595 elderly patients with CHS and randomized them into the training group (419 cases) and validation group (176 cases) at a ratio of 7:3. Age, sex, grade, histology, M stage, surgery and tumor size were identified as independent prognostic factors of this population. The novel nomogram displayed excellent predictive performance, which can be accessible by https://nomoresearch.shinyapps.io/elderlywithCHS/, with a C-index of 0.800 for the training group and 0.789 for the validation group. The value AUC values at 12-, 24-, and 36-month of 0.866, 0.855, and 0.860 in the training group and of 0.839, 0.856, and 0.840 in the validation group, respectively. The calibration curves exhibited good concordance from the predicted survival probabilities to actual observation. The ROC curves, IDI, NRI, and DCA showed the nomogram was superior to the existing AJCC staging system.ConclusionThis study developed a novel web-based nomogram for accurately predicting probabilities of OS in elderly patients with CHS, which will contribute to personalized survival assessment and clinical management for elderly patients with CHS.

Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis

“…Metastasis is considered one of the most notable prognostic indicators of POSNs, and it is incorporated into almost all previously reported prognostic models established for patients with initially diagnosed POSNs (19,20). Not only in POSNs but also in other malignancies, as soon as patients develop metastatic disease, their survival rate will drop dramatically compared with their counterparts without DM (24)(25)(26). In the present study, 238 (17.70%) cases were confirmed to have distant organ metastasis at the time of initial diagnosis, as shown in Figure 2.…”

Individualized assessment predictive models for risk and overall survival in elderly patients of primary kidney cancer with bone metastases: A large population-based study

“…All of our data were downloaded from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database via SEER Stat 8.4.1. 1 The database is currently the largest and publicly available cancer database, containing 18 cancer registries covering approximately 28% of the United States population ( 17 ). The SEER database started recording complete cancer metastasis sites from 2010 and for patients to have sufficient follow-up time records, so we selected all KC patient data from 2010 to 2015.…”

Two simple-to-use web-based nomograms to predict overall survival and cancer-specific survival in patients with extremity fibrosarcoma

“…Nowadays, the American Joint Committee on Cancer (AJCC) tumor node metastasis TNM staging system, incorporated with the anatomical information of the extent of the primary tumor (T), regional lymph nodes (N), and distant metastases (M), is widely used to assess the prognosis of cancer patients. Although the TNM staging system is considered as standard protocol for prognosis evaluation for patients with malignancies, several studies have shown that the current TNM staging system for STS patients is inadequate in regard to the correctness of N staging and individualized variability ( 9 , 10 ). In addition, the absence of a staging system with clinical and pathological features will also lead to a dilemma in treatment algorithm and prognostic assessment.…”